Open Access, Peer-reviewed
pISSN 2288-6478
eISSN 2288-6761
    J Korean Soc Menopause. 2011 Dec;17(3):155-159. Korean.
    Published online Dec 31, 2011.
    https://doi.org/10.6118/jksm.2011.17.3.155
    Copyright © 2011 by The Korean Society of Menopause
    Original Article

    Prevalence of Human Papilloma Virus Infection in Perimenopausal Women in Bucheon Province

    Junsik Park, M.D., Tae-Hee Kim, M.D., Ph.D., Hae-Hyeog Lee, M.D., Ph.D., Woo Seok Lee, M.D., Ph.D. and Soo-Ho Chung, M.D.
      • Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
    • Corresponding author (Email: heeobgy@schmc.ac.kr )
    Received August 25, 2011; Accepted November 04, 2011.

    Abstract

    Objectives

    To investigate the prevalence of human papillomavirus (HPV) infection in Bucheon province.

    Methods

    Two hundred eighty Korean women (average age 41.9, range 21~90 years) were enrolled, who received a regular thinprep pap test and an HPV deoxyribonucleic acid (DNA) chip test simultaneously at Soonchunhyang University Hospital, Bucheon, from February 2011 to March 2011.

    Results

    The overall prevalence of HPV infection was 33.9% (95/280). The prevalence of HPV infection in postmenopausal women (24.3%) was significantly lower than that of premenopausal women (37.1%, P = 0.049).

    Conclusion

    Although the prevalence of HPV infection in postmenopausal women was lower than that of premenopausal women, HPV infection is more critical in postmenopausal women as HPV infection in postmenopausal women is more likely to induce cervical cancer than in premenopausal women.

    Keywords
    Human papillomavirus; Menopause; Perimenopause; Prevalence; Women

    Tables

    Table 1
    Univariate comparison between the human papillomavirus (-) group and human papillomavirus (+) group

    Table 2
    Human papillomavirus test & gynecological disease cross tabulation

    Table 3
    The rate of human papillomavirus infection by menopause status

    Table 4
    The distribution of HPV infection by risk group

    References

      1. World Health OrganizationHuman papillomavirus and HPV vaccines: technical information for policy-makers and health professionals. Geneva: World Health Organization; 2007 [cited by 2011 Aug 1].
        Available from: http://whqlibdoc.who.int/hq/2007/WHO_IVB_07.05_eng.pdf.
      1. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813–819.
      1. Pham TH, Nguyen TH, Herrero R, Vaccarella S, Smith JS, Nguyen Thuy TT, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003;104:213–220.
      1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796–802.
      1. Stanley M. Immune responses to human papillomavirus. Vaccine 2006;24 Suppl 1:S16–S22.
      1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17–27.
      1. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006;24 Suppl 3:S3, S26–S34.
      1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244–265.
      1. Sasagawa T, Basha W, Yamazaki H, Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001;10:45–52.
      1. Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001;183:8–15.
      1. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999;3:i–iv. 1–196.
      1. Park HB, Suh YH, Park CH. Clinical efficacy of cervicography in patients with atypical squamous cells of undetermined significance (ASCUS) on cervical cytology. Korean J Obstet Gynecol 2003;46:362–377.
      1. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003;103:413–421.
      1. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464–474.
      1. Joo WD, Kim SH, Kim DY, Suh DS, Kim JH, Kim YM, et al. Prevalence of human papillomavirus infection in Korean women : risks of abnormal pap smear and cervical neoplasia. Korean J Gynecol Oncol Colposc 2004;15:309–316.
      1. Bae JH, Lee SJ, Kim CJ, Hur SY, Park YG, Lee WC, et al. Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 2008;18:788–794.
      1. Bratti MC, Rodriguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10,000 women in Guanacaste, Costa Rica. Rev Panam Salud Publica 2004;15:75–89.
      1. Grinsztejn B, Veloso VG, Levi JE, Velasque L, Luz PM, Friedman RK, et al. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int J Infect Dis 2009;13:72–80.
      1. Kim YT. Natural history of HPV and carcinogenesis of cervical cancer. Korean J Obstet Gynecol 2007;50:711–720.
    Cited by
    Crossref 5
    Google Scholar 
    MeSH Terms
    DNA
    Female
    Humans
    Menopause
    Papilloma
    Perimenopause
    Prevalence
    Uterine Cervical Neoplasms
    Viruses
    Metrics
    Share
    Tables
    slide
    slide
    slide
    slide

    1 / 4

    PERMALINK